[Study on the clinical misdiagnosis of hepatolenticular degeneration]

J Hu1, D Lü, G Wang

  • 1Hospital Affiliated to Institute of Neurology, Anhui College of TCM, Hefei 230061, China.

Zhonghua Yi Xue Za Zhi
|January 19, 2002
PubMed

Insights

Hepatolenticular degeneration (HLD) is frequently misdiagnosed, delaying critical treatment. Early diagnosis significantly improves patient outcomes, highlighting the need for prompt identification and intervention for this rare genetic disorder.

Area of Science:

  • Neurology
  • Medical Diagnostics
  • Genetics

Context:

  • Hepatolenticular degeneration (HLD), also known as Wilson's disease, is a rare autosomal recessive genetic disorder.
  • HLD affects copper metabolism, leading to copper accumulation in organs like the liver, brain, and eyes.
  • Delayed diagnosis of HLD can result in severe, irreversible organ damage and neurological complications.

Purpose:

  • To determine the incidence and patterns of misdiagnosis for hepatolenticular degeneration (HLD).
  • To investigate the relationship between diagnostic delays and treatment outcomes in HLD patients.
  • To identify strategies for improving the early detection and management of HLD.

Summary:

  • Over 51% of 1,011 analyzed HLD cases were misdiagnosed, with nearly 20% lacking a specific diagnosis for over three months.
  • Patients were misdiagnosed with over 100 conditions, including hepatitis, cirrhosis, and various neurological disorders.
  • Early diagnosis (within three months) was associated with significantly better treatment outcomes compared to delayed or missed diagnoses (P < 0.01).

Impact:

  • Highlights the critical need for increased awareness and diagnostic accuracy for HLD among clinicians.
  • Emphasizes that prompt diagnosis and initiation of treatment are crucial for improving patient prognosis and preventing long-term complications.
  • Suggests incorporating specific tests like Kayser-Fleischer (K-F) ring examination and copper metabolism tests for suspected HLD cases.
Abstract

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...